Compare Bio Protocol (BIO) vs Wanchain (WAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Wanchain — how do they compare? Bio Protocol trades at Rp493.59 (market cap Rp1,11T, Rp291,14M 24h volume), while Wanchain trades at Rp942.12 (market cap Rp240,51M, Rp39,98M 24h volume). The key difference: Bio Protocol is far larger — about 4615.2× Wanchain's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 198,9M / 210M WAN (95%) for Wanchain. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Wanchain for 25 Days on average.
| BIO | WAN | |
|---|---|---|
Market Cap | Rp1,11T | Rp240,51M |
Volume (24h) | Rp291,14M | Rp39,98M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 198,9M / 210M WAN (95%) |
Typical Hold Time | 16 Days | 25 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Wanchain currently holds a market cap of Rp240.51 million with 95% of its max supply in circulation. The asset shows moderate network activity with a 25-day average hold time, indicating some investor patience. Trading volumes appear limited, and no major protocol upgrades or ecosystem expansions have been reported recently, suggesting a period of consolidation.
Overall outlook is neutral with key opportunities in potential future interoperability developments. Major risks include low liquidity and high volatility typical of smaller-cap cryptocurrencies. Investors should monitor for any new exchange listings or protocol updates that could drive adoption.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Wanchain
WAN is the native cryptocurrency of the Wanchain Layer 1 blockchain, used for transactions and smart contract execution. A portion of WAN is burned with each transaction. The total supply is capped at 210,000,000.
Read more on WAN →
